Haya Ascher‐Svanum - Publications, H-index & Citations

Haya Ascher‐Svanum

Eli Lilly

43H指数

336论文数

5.6K被引数

收录论文 103

发表时间

Assessing the infrequent oral supplementation of olanzapine long-acting injection in the treatment of schizophrenia

EUROPEAN PSYCHIATRY

IF6.7

2020-04-16

PREAI

Ascher-Svanum, H.; Peng, X.; Montgomery, W.; Faries, D. E.; Lawson, A. H.; Witte, M. M.; Novick, D.; Jemiai, N.; Perrin, E.; McDonnell, D. P.

Effect of diabetes on caregiver burden in an observational study of individuals with Alzheimer's disease 阿尔茨海默病患者观察性研究中糖尿病对照顾者负担的影响

BMC GERIATRICS

IF3.8

2016-05-03

OAAI

Lebrec, Jeremie; Ascher-Svanum, Haya; Chen, Yun-Fei; Reed, Catherine; Kahle-Wrobleski, Kristin; Hake, Ann Marie; Raskin, Joel; Naderali, Ebrahim; Schuster, Dara; Heine, Robert J.; Kendall, David M.

Cognitive and Functional Decline in Patients With Mild Alzheimer Dementia With or Without Comorbid Diabetes

CLINICAL THERAPEUTICS

IF3.6

2015-06-01

OAAI

Ascher-Svanum, Haya; Chen, Yun-Fei; Hake, Ann; Kahle-Wrobleski, Kristin; Schuster, Dara; Kendall, David; Heine, Roberti

COST IMPLICATIONS OF EARLY DISCONTINUATION AND RESTART OF INSULIN IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS

VALUE IN HEALTH

IF6

2014-05-01

OAAI

Ascher-Svanum, H.; Lage, M. J.; Perez, M.; Reaney, M. D.; Lorraine, J.; Rodriguez, A.; Treglia, M.

Characteristics of patients misdiagnosed with Alzheimer's disease and their medication use: an analysis of the NACC-UDS database

BMC GERIATRICS

IF3.8

2013-12-19

OAAI

Gaugler, Joseph E.; Ascher-Svanum, Haya; Roth, David L.; Fafowora, Tolulope; Siderowf, Andrew; Beach, Thomas G.

The longitudinal interplay between negative and positive symptom trajectories in patients under antipsychotic treatment: a post hoc analysis of data from a randomized, 1-year pragmatic trial

BMC PSYCHIATRY

IF3.6

2013-11-28

OAAI

Chen, Lei; Johnston, Joseph A.; Kinon, Bruce J.; Stauffer, Virginia; Succop, Paul; Marques, Tiago R.; Ascher-Svanum, Haya

Predictors of psychiatric hospitalization during 6 months of maintenance treatment with olanzapine long-acting injection: post hoc analysis of a randomized, double-blind study

BMC PSYCHIATRY

IF3.6

2013-09-16

OAAI

Ascher-Svanum, Haya; Novick, Diego; Maria Haro, Josep; Bertsch, Jordan; McDonnell, David; Detke, Holland

EFFECTIVENESS OF OLANZAPINE IN THE TREATMENT OF SYMPTOMATIC SCHIZOPHRENIA PATIENTS WHO SWITCHED FROM CONVENTIONAL ANTIPSYCHOTICS IN CHINA

VALUE IN HEALTH

IF6

2013-05-01

OAAI

Montgomery, W.; Ye, W. W.; Kadziola, Z.; Treuer, T.; Liu, L. L.; Xue, H. B. H.; Wu, S. H.; Ascher-Svanum, H.

INCREASED BURDEN ON PRIMARY CARE PHYSICIANS PRECEDING DIAGNOSIS OF ALZHEIMER'S DISEASE IN THE UNITED KINGDOM

VALUE IN HEALTH

IF6

2013-05-01

OAAI

Chen, L.; Reed, C.; Happich, M.; Nyhuis, A.; Faries, D. E.; Ascher-Svanum, H.; Lenox-Smith, A.

Time to all-cause treatment discontinuation of olanzapine compared to other antipsychotics in the treatment of schizophrenia: A systematic review and meta-analysis 与其他抗精神病药相比，奥氮平治疗精神分裂症的全因治疗停药时间: 系统评价和荟萃分析

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2013-02-01

PREAI

Soares-Weiser, Karla; Bechard-Evans, Laura; Lawson, Anthony Howard; Davis, John; Ascher-Svanum, Haya

Predicting a 'Combined Treatment Outcome' in Chronic Schizophrenia: The Role of Demographics, Symptomatology, Functioning and Subjective Well-being

PHARMACOPSYCHIATRY

IF2.2

2013-01-04

OAAI

Naber, D.; Kollack-Walker, S.; Chen, J.; Stauffer, V. L.; Kinon, B. J.; Case, M.; Ascher-Svanum, H.; Kapur, S.; Kane, J. M.

Empirically driven definitions of good, moderate, and poor levels of functioning in the treatment of schizophrenia

QUALITY OF LIFE RESEARCH

IF2.7

2012-12-14

OAAI

Ascher-Svanum, Haya; Novick, Diego; Haro, Josep Maria; Aguado, Jaume; Cui, Zhanglin

Long-term healthcare costs and functional outcomes associated with lack of remission in schizophrenia: a post-hoc analysis of a prospective observational study

BMC PSYCHIATRY

IF3.6

2012-12-05

OAAI

Haynes, Virginia S.; Zhu, Baojin; Stauffer, Virginia L.; Kinon, Bruce J.; Stensland, Michael D.; Xu, Lei; Ascher-Svanum, Haya

Validation of a clinician questionnaire to assess reasons for antipsychotic discontinuation and continuation among patients with schizophrenia

PSYCHIATRY RESEARCH

IF3.9

2012-12-01

PREAI

Matza, Louis S.; Phillips, Glenn A.; Revicki, Dennis A.; Ascher-Svanum, Haya; Malley, Karen G.; Palsgrove, Andrew C.; Faries, Douglas E.; Stauffer, Virginia; Kinon, Bruce J.; Awad, A. George; Keefe, Richard S. E.; Naber, Dieter

DOES PARTICIPATION IN A WEIGHT CONTROL PROGRAM ALSO IMPROVE CLINICAL AND FUNCTIONAL OUTCOMES FOR CHINESE PATIENTS WITH SCHIZOPHRENIA TREATED WITH OLANZAPINE?

VALUE IN HEALTH

IF6

2012-11-01

OAAI

Montgomery, W.; Treuer, T.; Ye, W. W.; Xue, H. B. H.; Wu, S. H.; Liu, L. L.; Kadziola, Z.; Ascher-Svanum, H.

Construct validity of 2 measures to assess reasons for antipsychotic discontinuation and continuation from patients' and clinicians' perspectives in a clinical trial

BMC MEDICAL RESEARCH METHODOLOGY

IF3.4

2012-09-13

OAAI

Faries, Douglas; Ascher-Svanum, Haya; Phillips, Glenn; Nyhuis, Allen W.; Sugihara, Tomoko; Stauffer, Virginia; Kinon, Bruce J.

Improved outcomes following a switch to olanzapine treatment from risperidone treatment in a 1-year naturalistic study of schizophrenia patients in Japan

PSYCHIATRY AND CLINICAL NEUROSCIENCES

IF6.2

2012-05-25

OAAI

Ye, Wenyu; Fujikoshi, Shinji; Nakahara, Naohiro; Takahashi, Michihiro; Ascher-Svanum, Haya; Ohmori, Tetsuro

Treatment response trajectories and antipsychotic medications: Examination of up to 18 months of treatment in the CATIE chronic schizophrenia trial.

SCHIZOPHRENIA RESEARCH

IF3.5

2012-05-01

PREAI

Levine, Stephen Z.; Rabinowitz, Jonathan; Faries, Douglas; Lawson, Anthony H.; Ascher-Svanum, Haya

LONG-TERM FUNCTIONAL IMPROVEMENTS IN THE 2-YEAR TREATMENT OF SCHIZOPHRENIA OUTPATIENTS WITH OLANZAPINE LONG-ACTING INJECTION

SCHIZOPHRENIA RESEARCH

IF3.5

2012-04-01

PREAI

Ascher-Svanum, Haya; Novick, Diego; Haro, Josep M.; Bertsch, Jordan; McDonnell, David; Detke, Holland

LONG-TERM HEALTHCARE COSTS AND FUNCTIONAL OUTCOMES ASSOCIATED WITH LACK OF REMISSION IN SCHIZOPHRENIA

SCHIZOPHRENIA RESEARCH

IF3.5

2012-04-01

PREAI

Haynes, Virginia S.; Zhu, Baojin; Stauffer, Virginia; Kinon, Bruce J.; Xu, Lei; Ascher-Svanum, Haya

研究方向